Drug Profile
Research programme: protein-protein inhibitors - Eisai/Paoli Calmettes
Alternative Names: PPI - Eisai/Paoli CalmettesLatest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Eisai Inc
- Developer Eisai Inc; Paoli-Calmettes-institute
- Class Antineoplastics
- Mechanism of Action Protein-protein interaction inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer